compound 9g [PMID: 24412111] [Ligand Id: 8509] activity data from GtoPdb and ChEMBL

Click here for a description of the charts and data table

Please tell us if you are using this feature and what you think!

ChEMBL ligand: CHEMBL3115390
  • BB3 receptor/Bombesin receptor subtype-3 in Human [ChEMBL: CHEMBL4080] [GtoPdb: 40] [UniProtKB: P32247]
  • BB3 receptor/Bombesin receptor subtype-3 in Mouse [ChEMBL: CHEMBL1075140] [GtoPdb: 40] [UniProtKB: O54798]
There should be some charts here, you may need to enable JavaScript!
DB Assay description Assay Type Standard value Standard parameter Original value Original units Original parameter Reference
BB3 receptor/Bombesin receptor subtype-3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4080] [GtoPdb: 40] [UniProtKB: P32247]
ChEMBL Agonist activity at human BRS-3 expressed in CHOK1 cells after 1 hr by HTRF assay B 8.77 pEC50 1.7 nM EC50 Bioorg Med Chem Lett (2014) 24: 750-755 [PMID:24412111]
ChEMBL Agonist activity at human BRS3 expressed in CHO-K1 cells by IP-One HTRF assay B 8.77 pEC50 1.7 nM EC50 Bioorg Med Chem (2015) 23: 89-104 [PMID:25497965]
GtoPdb - - 8.77 pEC50 1.7 nM EC50 Bioorg Med Chem Lett (2014) 24: 750-5 [PMID:24412111];
Peptides (2016) 75: 8-17 [PMID:26524625];
J Pharmacol Exp Ther (2022) 382: 66-78 [PMID:35644465]
BB3 receptor/Bombesin receptor subtype-3 in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1075140] [GtoPdb: 40] [UniProtKB: O54798]
ChEMBL Agonist activity at mouse BRS-3 expressed in CHOK1 cells after 1 hr by HTRF assay B 8.46 pEC50 3.5 nM EC50 Bioorg Med Chem Lett (2014) 24: 750-755 [PMID:24412111]
ChEMBL Agonist activity at mouse BRS3 expressed in CHO-K1 cells by IP-One HTRF assay B 8.46 pEC50 3.5 nM EC50 Bioorg Med Chem (2015) 23: 89-104 [PMID:25497965]

ChEMBL data shown on this page come from version 34:

Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]